Several other analysts also recently weighed in on ZLTQ. Brean Capital reiterated a buy rating on shares of ZELTIQ Aesthetics in a research note on Monday, October 24th. Zacks Investment Research upgraded ZELTIQ Aesthetics from a hold rating to a buy rating and set a $41.00 price target on the stock in a research note on Wednesday, October 26th. Canaccord Genuity boosted their price target on ZELTIQ Aesthetics from $41.00 to $45.00 and gave the company a buy rating in a research note on Thursday, November 10th. Northcoast Research reiterated a buy rating on shares of ZELTIQ Aesthetics in a research note on Tuesday, November 8th. Finally, Aegis started coverage on ZELTIQ Aesthetics in a research note on Wednesday, December 7th. They set a buy rating and a $51.00 price target on the stock. One research analyst has rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the stock. The stock has a consensus rating of Buy and an average target price of $44.60.
ZELTIQ Aesthetics (NASDAQ:ZLTQ) traded up 12.85% during trading on Monday, reaching $55.75. 1,753,610 shares of the company’s stock were exchanged. ZELTIQ Aesthetics has a 12 month low of $18.41 and a 12 month high of $55.85. The stock has a market cap of $2.23 billion, a PE ratio of 71.94 and a beta of 1.01. The firm has a 50 day moving average of $43.48 and a 200-day moving average of $39.95.
This story was originally posted by sleekmoney and is owned by of sleekmoney. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at http://sleekmoney.com/zeltiq-aesthetics-inc-zltq-lowered-to-hold-at-maxim-group/1658561.html.
In other ZELTIQ Aesthetics news, insider Keith J. Sullivan sold 8,000 shares of the stock in a transaction that occurred on Monday, December 5th. The stock was sold at an average price of $43.78, for a total transaction of $350,240.00. Following the transaction, the insider now owns 87,198 shares in the company, valued at $3,817,528.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mark J. Foley sold 10,000 shares of the stock in a transaction that occurred on Friday, January 13th. The stock was sold at an average price of $41.72, for a total value of $417,200.00. Following the transaction, the insider now owns 219,939 shares in the company, valued at approximately $9,175,855.08. The disclosure for this sale can be found here. Insiders have sold 57,600 shares of company stock worth $2,535,120 in the last quarter. 15.60% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of ZLTQ. Victory Capital Management Inc. acquired a new stake in shares of ZELTIQ Aesthetics during the third quarter valued at about $32,088,000. Palo Alto Investors LLC boosted its stake in shares of ZELTIQ Aesthetics by 142.5% in the second quarter. Palo Alto Investors LLC now owns 1,391,079 shares of the company’s stock worth $38,018,000 after buying an additional 817,443 shares during the period. EverPoint Asset Management LLC acquired a new position in ZELTIQ Aesthetics during the second quarter valued at $15,032,000. Point72 Asset Management L.P. increased its position in ZELTIQ Aesthetics by 30.7% in the second quarter. Point72 Asset Management L.P. now owns 2,219,762 shares of the company’s stock valued at $60,666,000 after buying an additional 521,462 shares in the last quarter. Finally, Jennison Associates LLC increased its position in ZELTIQ Aesthetics by 2,588.1% in the third quarter. Jennison Associates LLC now owns 300,315 shares of the company’s stock valued at $11,778,000 after buying an additional 289,143 shares in the last quarter.
About ZELTIQ Aesthetics
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/zeltiq-aesthetics-inc-zltq-lowered-to-hold-at-maxim-group/1658561.html
Receive News & Ratings for ZELTIQ Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZELTIQ Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.